jhoonline.org/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Journal of Hematology & Oncology
official impact factor 3.99
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Journal of Hematology & Oncology

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Archive
  • Supplements

Page 1 of 4

1 2 3 4  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

1.

1442
Accesses

Review   Open Access Highly Accessed

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin Journal of Hematology & Oncology 2011, 4:10 (22 March 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

2.

1218
Accesses

Review   Open Access Highly Accessed

MEK and the inhibitors: from bench to bedside

Akintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, Pavan Ravella, Delong Liu Journal of Hematology & Oncology 2013, 6:27 (12 April 2013)

Abstract | Full text | PDF | ePUB | PubMed | Cited on BioMed Central

3.

1192
Accesses

Review   Open Access Highly Accessed

Clinical applications of mesenchymal stem cells

Shihua Wang, Xuebin Qu, Robert Zhao Journal of Hematology & Oncology 2012, 5:19 (30 April 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

4.

1063
Accesses

Review   Open Access Highly Accessed

The effects of β-glucan on human immune and cancer cells

Godfrey Chan, Wing Chan, Daniel Sze Journal of Hematology & Oncology 2009, 2:25 (10 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

5.

916
Accesses

Research   Open Access

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

Saad Z Usmani, Robert D Bona, Gabriela Chiosis, Zihai Li Journal of Hematology & Oncology 2010, 3:40 (26 October 2010)

Abstract | Full text | PDF | PubMed

6.

887
Accesses

Short report   Open Access

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

Lieke H van der Helm, Ellen RM Scheepers, Nic JGM Veeger, Simon MGJ Daenen, André B Mulder, Eva van den Berg, Edo Vellenga, Gerwin Huls Journal of Hematology & Oncology 2013, 6:29 (16 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

7.

782
Accesses

Review   Open Access Highly Accessed

Targeted drug delivery for cancer therapy: the other side of antibodies

Michael A Firer, Gary Gellerman Journal of Hematology & Oncology 2012, 5:70 (9 November 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

8.

766
Accesses

Review   Open Access

B-Raf and the inhibitors: from bench to bedside

Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, Delong Liu Journal of Hematology & Oncology 2013, 6:30 (25 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

9.

749
Accesses

Review   Open Access Highly Accessed

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang, Xiao-feng Yang Journal of Hematology & Oncology 2013, 6:19 (25 February 2013)

Abstract | Full text | PDF | PubMed

10.

719
Accesses

Short report   Open Access

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller, Martin Schreder, Christoph Tinchon, Michael Pfeilstocker, Susanne Steinkirchner, Thomas Melchardt, Martina Mitrovic, Michael Girschikofsky, Alois Lang, Peter Krippl, Thamer Sliwa, Alexander Egle, Werner Linkesch, Daniela Voskova, Hubert Angermann, Richard Greil Journal of Hematology & Oncology 2013, 6:32 (29 April 2013)

Abstract | Full text | PDF | PubMed

11.

670
Accesses

Case report   Open Access Highly Accessed

Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature

Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen Journal of Hematology & Oncology 2008, 1:26 (18 December 2008)

Abstract | Full text | PDF | PubMed

12.

662
Accesses

Review   Open Access Highly Accessed

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

Jie Li, Oluwole Fadare, Li Xiang, Beihua Kong, Wenxin Zheng Journal of Hematology & Oncology 2012, 5:8 (9 March 2012)

Abstract | Full text | PDF | PubMed

13.

618
Accesses

Review   Open Access Highly Accessed

Mechanism of action of lenalidomide in hematological malignancies

Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das, Amit Verma Journal of Hematology & Oncology 2009, 2:36 (12 August 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

14.

616
Accesses

Case report   Open Access

De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome

Xiao Min, Zhang Na, Liu Yanan, Li Chunrui Journal of Hematology & Oncology 2011, 4:45 (10 November 2011)

Abstract | Full text | PDF | PubMed

15.

598
Accesses

Research   Open Access

Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition

Beverly L Falcon, Belinda O’Clair, Don McClure, Glenn F Evans, Julie Stewart, Michelle L Swearingen, Yuefeng Chen, Kevin Allard, Linda N Lee, Kuldeep Neote, Dyke P McEwen, Mark T Uhlik, Sudhakar Chintharlapalli Journal of Hematology & Oncology 2013, 6:31 (27 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

16.

519
Accesses

Review   Open Access Highly Accessed

Light chain (AL) amyloidosis: update on diagnosis and management

Michael Rosenzweig, Heather Landau Journal of Hematology & Oncology 2011, 4:47 (18 November 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

17.

514
Accesses

Research   Open Access

Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia

Maoxiang Qian, Wen Jin, Xuehua Zhu, Xiaohong Jia, Xianwen Yang, Yanzhi Du, Kankan Wang, Ji Zhang Journal of Hematology & Oncology 2013, 6:25 (2 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

18.

496
Accesses

Review   Open Access

Targeting p53 by small molecules in hematological malignancies

Manujendra N Saha, Lugui Qiu, Hong Chang Journal of Hematology & Oncology 2013, 6:23 (27 March 2013)

Abstract | Full text | PDF | ePUB | PubMed

19.

477
Accesses

Short report   Open Access

Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia

Oumar Samassekou, Abba Malina, Josée Hébert, Ju Yan Journal of Hematology & Oncology 2013, 6:26 (2 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

20.

478
Accesses

Short report   Open Access

Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen

Yan Zhuang, Xiang Wang, Hong T Nguyen, Ying Zhuo, Xinpeng Cui, Claire Fewell, Erik K Flemington, Bin Shan Journal of Hematology & Oncology 2013, 6:35 (13 May 2013)

Abstract | Full text | PDF | PubMed

21.

477
Accesses

Letter to the Editor   Open Access

The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia

Andreia Maria Camargos Rocha, Cláudia Souza, Gifone Aguiar Rocha, Fabrício Freire de Melo, Nelma Cristina Diogo Clementino, Marília Campos Abreu Marino, Dulciene Maria Magalhães Queiroz Journal of Hematology & Oncology 2013, 6:28 (12 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

22.

452
Accesses

Review   Open Access Highly Accessed

Therapeutic advancement of chronic lymphocytic leukemia

Kang Lu, Xin Wang Journal of Hematology & Oncology 2012, 5:55 (16 September 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

23.

432
Accesses

Research   Open Access

Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects

Mazin A Zamzami, John A Duley, Gareth R Price, Deon J Venter, John W Yarham, Robert W Taylor, Laurence P Catley, Timothy HJ Florin, Anthony M Marinaki, Francis Bowling Journal of Hematology & Oncology 2013, 6:24 (29 March 2013)

Abstract | Provisional PDF | PubMed

24.

419
Accesses

Research   Open Access Highly Accessed

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

Bernardo HL Goulart, Jeffrey W Clark, Gregory Y Lauwers, David P Ryan, Nina Grenon, Alona Muzikansky, Andrew X Zhu Journal of Hematology & Oncology 2009, 2:13 (16 March 2009)

Abstract | Full text | PDF | PubMed

25.

421
Accesses

Review   Open Access Highly Accessed

Chemotherapy in advanced bladder cancer: current status and future

Nabil Ismaili, Mounia Amzerin, Aude Flechon Journal of Hematology & Oncology 2011, 4:35 (9 September 2011)

Abstract | Full text | PDF | PubMed

Page 1 of 4

1 2 3 4  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.